
簡要描述:Recombinant Mouse IFN-γ Protein,Lyophilized from a 0.2 um filtered solution in 20 mM Tris-HCI pH8.0, 300 mM NaCl, containing 5 % trehalose, 0.05 % Tween-20.
產(chǎn)品分類
Product Category詳細介紹
| 品牌 | absin | 純度 | > 96 % |
|---|---|---|---|
| 貨號 | abs01021 | 規(guī)格 | 100ug |
| 供貨周期 | 現(xiàn)貨 | 應用領域 | 化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合 |
Recombinant Mouse IFN-γ Protein
| 概述 | |
| 別名 | IFN-γ蛋白 |
| 種屬 | Murine |
| 來源 | Escherichia coli. |
| 形態(tài) | Lyophilized from a 0.2 um filtered solution in 20 mM Tris-HCI pH8.0, 300 mM NaCl, containing 5 % trehalose, 0.05 % Tween-20.(于2022.12.16更新) |
| 性能 | |
| 序列 | HGTVIESLES LNNYFNSSGI DVEEKSLFLD IWRNWQKDGD MKILQSQIIS FYLRLFEVLK DNQAISNNIS VIESHLITTF FSNSKAKKDA FMSIAKFEVN NPQVQRQAFN ELIRVVHQLL PESSLRKRKR SRC |
| 標簽 | No Tag |
| 純度 | > 96 % by SDS-PAGE and HPLC analyses. |
| 內(nèi)毒素水平 | Less than 1 EU/μg of rMuIFN-γ as determined by LAL method. |
| 活性 | Fully biologically active when compared to standard. The ED50 as determined by an anti-viral assay using murine L929 cells infected with encephalomyocarditis (EMC) virus is less than 0.8 ng/ml, corresponding to a specific activity of > 1.3 × 106 IU/mg. |
| 溶解方法 | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled 20 mM Tris-HCl pH8.0 with 50 mM NaCl to a concentration of 0.1-0.3 mg/ml. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions. |
| 儲存/保存方法 | 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution. Avoid repeated freeze/thaw cycles. |
| 靶標 | |
| Accession | P01580 |
| Gene IDs | 15978 |
| 參考文獻 | |
| 參考文獻 | 1. Pennino D, Bhavsar PK, Effner R, et al. 2012. J Allergy Clin Immunol, 2. Hibi M, Hachimura S, Ise W, et al. 2003. Cytotechnology, 43: 49-55. 3. Wang H, Ruan Z, Wang Y, et al. 2008. Mol Immunol, 45: 1548-56. 4. Kopinski P, Przybylski G, Jarzemska A, et al. 2007. Pol Merkur Lekarski, 23: 15-21. |
產(chǎn)品咨詢
